Quality control is critical for all gene-based and cell-based therapies; therefore, we adhere to strict guidelines in donor serology and microbial screening, process and equipment validation, records management, training, certifications, and project management to ensure the highest quality for our starting materials. This allows our clients to focus on their research projects aimed at improving human life and discovering proven methods to treat currently incurable diseases and disorders. Furthermore, we maintain up-to-date and rigorous training for our team of experts so that they are well prepared to generate top-of-the-line R&D products for our customer when it comes to their clinical research projects.
Verification and consistency • Standard 04
Quality Control
Screening, validation, records management, training, and project oversight reinforce the consistency of starting materials.
Policy and supporting detail
Quality Control
Read the complete source policy below. Questions about how a standard applies to a project can be directed to the LeoCorps team.
Need clarification?
Connect the standard to your requirements.
Contact LeoCorps to discuss donor criteria, material specifications, documentation needs, processing requirements, or order terms.
